HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anxiety modulates cognitive deficits in a perinatal glutathione deficit animal model of schizophrenia.

Abstract
In this study, we investigated long-term repercussion of early glutathione deficit by l-buthionine-(S,R)-sulfoximine (BSO) injections as a rat model of schizophrenia. BSO rats were tested through various behavioral tasks requiring animals to take into account previously delivered information. We showed that relative to controls, BSO rats (1) were less active and more anxious in an Elevated Plus Maze test, allowing us to split them into two subgroups with high and low anxiety levels; (2) demonstrated normal abilities of behavioral flexibility tested with a rat-adapted version of the Wisconsin Card Sorting Test (WCST), with even higher abilities in anxious BSO rats suggesting reduced interference of previously acquired rules; (3) did not forage normally in radial arm mazes and mainly used clockwise strategies; (4) exhibited a lack of habituation during a startle response task; and (5) showed a normal prepulse inhibition of the startle response (PPI) and a normal conditioned taste aversion (CTA). All these results indicate that early glutathione deficit provokes persistent changes in adulthood and improves the validity of this animal model of schizophrenia. They further suggest difficulties binding temporally separated events (WCST), except when the salience of this information is very strong (CTA). We propose that the transient glutathione deficit during cerebral development could alter a "cognitive binding" process in interaction with the emotional state that could possibly account for the disruption of integrative function that characterizes schizophrenia.
AuthorsD Preissmann, M Dépré, F Schenk, P Gisquet-Verrier
JournalBrain research (Brain Res) Vol. 1648 Issue Pt A Pg. 459-468 (10 01 2016) ISSN: 1872-6240 [Electronic] Netherlands
PMID27485658 (Publication Type: Journal Article)
CopyrightCopyright © 2016 Elsevier B.V. All rights reserved.
Chemical References
  • Buthionine Sulfoximine
  • Glutathione
Topics
  • Animals
  • Anxiety (chemically induced, complications)
  • Avoidance Learning (drug effects)
  • Behavior, Animal (drug effects)
  • Buthionine Sulfoximine (administration & dosage, analogs & derivatives)
  • Cognitive Dysfunction (chemically induced, complications)
  • Disease Models, Animal
  • Glutathione (deficiency)
  • Locomotion (drug effects)
  • Male
  • Prepulse Inhibition (drug effects)
  • Rats
  • Rats, Wistar
  • Reflex, Startle (drug effects)
  • Schizophrenia (chemically induced, complications)
  • Schizophrenic Psychology

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: